Holen Sie sich die Stockscreener-App
1.3804
0.03%
0.0004
Schlusskurs vom Vortag:
$1.38
Offen:
$1.35
24-Stunden-Volumen:
644.29K
Relative Volume:
0.45
Marktkapitalisierung:
$256.39M
Einnahmen:
$156.37M
Nettoeinkommen (Verlust:
$-37.49M
KGV:
-6.5733
EPS:
-0.21
Netto-Cashflow:
$-47.77M
1W Leistung:
-3.47%
1M Leistung:
-16.34%
6M Leistung:
-18.32%
1J Leistung:
-21.57%
1-Tages-Spanne:
$1.35
$1.42
1-Wochen-Bereich:
$1.34
$1.47
52-Wochen-Spanne:
$1.34
$2.54
Cerus Corp Stock (CERS) Company Profile
Firmenname
Cerus Corp
Sektor
Branche
Telefon
(925) 288-6000
Adresse
1220 CONCORD AVENUE, CONCORD, CA
Vergleichen Sie CERS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CERS
Cerus Corp
|
1.385 | 256.39M | 156.37M | -37.49M | -47.77M | -0.21 |
|
ABT
Abbott Laboratories
|
131.58 | 225.32B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
100.51 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
374.29 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
88.48 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.97 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Cerus Corp Stock (CERS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-12 | Eingeleitet | Craig Hallum | Buy |
| 2023-01-20 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-01-17 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-10-08 | Fortgesetzt | BTIG Research | Buy |
| 2020-06-16 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-02-26 | Eingeleitet | BTIG Research | Buy |
| 2019-11-13 | Hochstufung | BTIG Research | Neutral → Buy |
| 2019-08-28 | Eingeleitet | Stifel | Buy |
| 2019-08-23 | Fortgesetzt | Stephens | Overweight |
| 2018-01-05 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2017-12-08 | Fortgesetzt | BTIG Research | Neutral |
| 2016-07-07 | Fortgesetzt | Cantor Fitzgerald | Buy |
| 2015-12-17 | Herabstufung | Wedbush | Outperform → Neutral |
| 2014-05-02 | Bestätigt | MLV & Co | Buy |
| 2013-04-24 | Bestätigt | Cantor Fitzgerald | Buy |
| 2013-03-15 | Bestätigt | MLV & Co | Buy |
| 2012-04-17 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2012-02-29 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2011-11-10 | Bestätigt | MLV & Co | Buy |
| 2011-06-03 | Eingeleitet | Wedbush | Outperform |
| 2011-03-04 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2010-03-09 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2009-08-26 | Hochstufung | Avondale | Mkt Perform → Mkt Outperform |
Alle ansehen
Cerus Corp Aktie (CERS) Neueste Nachrichten
Virtu Financial LLC Takes $33,000 Position in Cerus Co. (NASDAQ:CERS) - Defense World
How Are Things Looking For Cerus Corp (NASDAQ: CERS) For The Short Term? - stocksregister.com
Quantbot Technologies LP Acquires Shares of 52,913 Cerus Co. (NASDAQ:CERS) - Defense World
Head to Head Analysis: Cerus (NASDAQ:CERS) & DIH Holding US (NASDAQ:DHAI) - Defense World
Cerus stock touches 52-week low at $1.37 amid market challenges - Investing.com India
Cerus Leads Our Selection Of 3 Promising Penny Stocks - Yahoo Finance
CERUS CORP Executives Sell Shares - TradingView
Analysts Predict How High Cerus Corp (CERS) Will Go. - Stocks Register
Closing Bell Recap: Cerus Corp (CERS) Ends at 1.48, Reflecting a -0.67 Downturn - The Dwinnex
Cerus Corp COO Vivek Jayaraman sells $50,930 in stock By Investing.com - Investing.com South Africa
Cerus Stock: Insider Sales Amid Positive Business Growth - Sharewise
Cerus Corp chief medical officer sells $39,156 in stock By Investing.com - Investing.com Canada
Cerus Corp chief legal officer sells $41,130 in stock By Investing.com - Investing.com South Africa
Cerus corp CFO Kevin Green sells $46,659 in stock - Investing.com India
Cerus Corp chief legal officer sells $41,130 in stock - Investing.com
Cerus Corp CEO William Greenman sells $91,354 in stock - Investing.com
Cerus Corp chief medical officer sells $39,156 in stock - Investing.com
Cantor Fitzgerald maintains Cerus stock $4 target, Overweight rating - Investing.com
Cantor Fitzgerald maintains Cerus stock $4 target, Overweight rating By Investing.com - Investing.com UK
Cerus Co. (NASDAQ:CERS) Shares Purchased by Rhumbline Advisers - Defense World
Cerus Corp chief legal officer sells $104,885 in stock By Investing.com - Investing.com South Africa
Cerus secures CE mark approval for LED-based illumination device - Yahoo Finance
Cerus corp COO Vivek Jayaraman sells $16,692 in stock By Investing.com - Investing.com South Africa
Cerus corp CEO William Greenman sells shares worth $35,651 By Investing.com - Investing.com South Africa
Cerus Stock: Execs Sell Shares Amid Strong Financials - sharewise
Cerus CFO Kevin Green sells $108,658 in company stock By Investing.com - Investing.com South Africa
Cerus Corp chief medical officer sells $90,570 in stock By Investing.com - Investing.com South Africa
Cerus Corp chief medical officer sells $90,570 in stock - Investing.com India
Cerus corp COO Vivek Jayaraman sells $16,692 in stock - Investing.com India
Cerus corp CEO William Greenman sells shares worth $35,651 - Investing.com India
Cerus CFO Kevin Green sells $108,658 in company stock - Investing.com
Cerus Corp chief legal officer sells $104,885 in stock - Investing.com
Cerus Corporation Announces Receipt of CE Mark for Next-Generation INTERCEPT Illumination Device (INT200) - Yahoo Finance
Cerus Corp (NASDAQ: CERS) Stock Forecast: Could Pass $3 In A Year - Stocks Register
ARK Investment Management LLC Has $32.06 Million Stake in Cerus Co. (NASDAQ:CERS) - MarketBeat
Cerus (CERS) Expected to Announce Earnings on Tuesday - MarketBeat
CERUS CORP SEC 10-K Report - TradingView
Cerus (NASDAQ:CERS) Receives Overweight Rating from Cantor Fitzgerald - MarketBeat
Cerus targets 8%-11% revenue growth for 2025 with strong IFC demand and global expansion - MSN
Cerus Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo
Cerus: Q4 Earnings Snapshot - CTPost
Cerus Corp (CERS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Positive Cash Flow - Yahoo Finance
Cerus Corp (CERS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Positive Cash Flow By GuruFocus - Investing.com Canada
Earnings call transcript: Cerus Q4 2024 beats EPS forecast, stock dips - Investing.com
Cerus Corp (CERS) Q4 Earnings: Revenue Surpasses Estimates at $5 - GuruFocus.com
Cerus earnings beat by $0.01, revenue topped estimates - Investing.com
Cerus: Q4 Earnings Snapshot -February 20, 2025 at 04:21 pm EST - Marketscreener.com
Cerus Corporation Announces Full-Year and Fourth Quarter 2024 Financial Results - Yahoo Finance
What To Expect From Cerus Corp (CERS) Q4 2024 Earnings - GuruFocus.com
Cerus Corporation to Participate in the TD Cowen 45th Annual Health Care Conference - Yahoo Finance
Finanzdaten der Cerus Corp-Aktie (CERS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cerus Corp-Aktie (CERS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Jensen Chrystal | Chief Legal Officer |
Mar 13 '25 |
Sale |
1.45 |
18,949 |
27,476 |
813,369 |
| Jayaraman Vivek K | Chief Operating Officer |
Mar 14 '25 |
Sale |
1.45 |
46,004 |
66,706 |
1,431,326 |
| Jayaraman Vivek K | Chief Operating Officer |
Mar 13 '25 |
Sale |
1.45 |
29,985 |
43,478 |
1,477,330 |
| Greenman William Mariner | President and CEO |
Mar 14 '25 |
Sale |
1.45 |
122,827 |
178,099 |
4,115,845 |
| Greenman William Mariner | President and CEO |
Mar 13 '25 |
Sale |
1.45 |
71,086 |
103,075 |
4,238,672 |
| Green Kevin Dennis | Chief Financial Officer |
Mar 14 '25 |
Sale |
1.45 |
36,740 |
53,273 |
875,867 |
| Green Kevin Dennis | Chief Financial Officer |
Mar 13 '25 |
Sale |
1.45 |
23,147 |
33,563 |
912,607 |
| Benjamin Richard J | Chief Medical Officer |
Mar 14 '25 |
Sale |
1.45 |
30,075 |
43,609 |
685,775 |
| Benjamin Richard J | Chief Medical Officer |
Mar 13 '25 |
Sale |
1.45 |
18,949 |
27,476 |
715,850 |
| Jensen Chrystal | Chief Legal Officer |
Mar 07 '25 |
Sale |
1.50 |
27,457 |
41,131 |
832,318 |
0.61%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):